Literature DB >> 8804932

Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example.

M Ferrer1, J Alonso, L Prieto, V Plaza, E Monsó, R Marrades, M C Aguar, A Khalaf, J M Antó.   

Abstract

We describe the adaptation into Spanish of the St George's Respiratory Questionnaire (SGRQ), a self-administered questionnaire developed by Jones et al. (1991) covering three domains of health in airways disease patients: symptoms, activity and impacts. For the adaptation, the forward and back-translation method by bilinguals was used, together with professional committee and lay panel. Once tested for feasibility and comprehension, 318 male chronic obstructive pulmonary disease (COPD) patients with a wide range of disease severity completed the Spanish version of the SGRQ. The clinical status of the patients was evaluated concurrently with the measurement of health status. Lung function was assessed in the 2 months before or after the questionnaire administration. The Spanish version of the SGRQ was acceptable and easy to understand. Cronbach's alpha reliability coefficient was 0.94 for the overall scale and 0.72 for "Symptoms", 0.89 for "Activity", and 0.89 for "Impacts" subscales. Correlation coefficients between the overall score and dyspnoea and % forced expiratory volume in one second (FEV1) were 0.59 and -0.45, respectively, and these correlations were higher than those observed between the clinical variables and the Nottingham Health Profile, a generic measure of health-related quality of life. Results of the study suggest that the Spanish version of the SGRQ is conceptually equivalent to the original, and similarly reliable and valid. Although further studies should complete the adaptation work, results suggest that the SGRQ may already be used in Spain and in international studies involving Spanish respiratory patients. According to the present approach, it appears to be feasible to adapt a specific questionnaire on health-related quality of life in respiratory disease to another language and culture.

Entities:  

Mesh:

Year:  1996        PMID: 8804932     DOI: 10.1183/09031936.96.09061160

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  67 in total

1.  Demographic and clinical characteristics associated with quality of life in patients with chronic obstructive pulmonary disease.

Authors:  Signe Berit Bentsen; Christine Miaskowski; Tone Rustøen
Journal:  Qual Life Res       Date:  2013-09-03       Impact factor: 4.147

Review 2.  Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004.

Authors:  M Decramer; R Gosselink; M Rutten-Van Mölken; J Buffels; O Van Schayck; P-A Gevenois; R Pellegrino; E Derom; W De Backer
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

3.  Validation of a Spanish version of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis.

Authors:  Gerard Muñoz; Maria Buxó; Javier de Gracia; Casilda Olveira; Miguel Angel Martinez-Garcia; Rosa Giron; Eva Polverino; Antonio Alvarez; Surinder S Birring; Montserrat Vendrell
Journal:  Chron Respir Dis       Date:  2016-02-22       Impact factor: 2.444

4.  Health-related quality of life in asthma: a comparison between the St George's Respiratory Questionnaire and the Asthma Quality of Life Questionnaire.

Authors:  Carlos Sanjuás; Jordi Alonso; Luis Prieto; Montse Ferrer; Joan M Broquetas; Josep M Antó
Journal:  Qual Life Res       Date:  2002-12       Impact factor: 4.147

5.  Does the COPD assessment test (CAT(TM)) questionnaire produce similar results when self- or interviewer administered?

Authors:  A Agusti; J J Soler-Cataluña; J Molina; E Morejon; M Garcia-Losa; M Roset; X Badia
Journal:  Qual Life Res       Date:  2015-04-07       Impact factor: 4.147

6.  Evaluation of a combined strategy directed towards health-care professionals and patients with chronic obstructive pulmonary disease (COPD): information and health education feedback for improving clinical monitoring and quality-of-life.

Authors:  Carles Valero; Mònica Monteagudo; Maria Llagostera; Xavier Bayona; Sílvia Granollers; Mateo Acedo; Juan J Ferro; Lluïsa Rodríguez-Latre; Jesús Almeda; Laura Muñoz
Journal:  BMC Public Health       Date:  2009-12-01       Impact factor: 3.295

7.  Antibiotic treatment of exacerbations of COPD in general practice: long-term impact on health-related quality of life.

Authors:  Marc Miravitlles; Carles Llor; Jesús Molina; Karlos Naberan; Josep M Cots; Fernando Ros
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-02-18

8.  Usefulness of inspiratory capacity measurement in COPD patients in the primary care setting.

Authors:  Antonio Madueño; Antonio Martín; Juan-Antonio Péculo; Esther Antón; Alejandra Paravisini; Antonio León
Journal:  Int J Gen Med       Date:  2009-12-29

9.  Incidence and risk factors of exacerbations among COPD patients in primary health care: APMPOC study.

Authors:  Eulàlia Borrell; Mar Rodríguez; Pere Torán; Laura Muñoz; Guillem Pera; Núria Montellà; Mònica Monteagudo; Magalí Urrea; Yolanda Puigfel; Antonio Negrete; Xavier Mezquiriz; Cristina Domènech; Anna Lacasta; Ma Llum García; Sandra Maneus; Glòria Tintoré
Journal:  BMC Public Health       Date:  2009-01-09       Impact factor: 3.295

10.  Measurement of the validity and reliability of the persian translation of the saint george respiratory questionnaire for patients with chronic obstructive pulmonary disease.

Authors:  Saeid Fallah Tafti; Ali Cheraghvandi; Mehran Marashian; Habib Emami; Bahareh Mokri
Journal:  Open Respir Med J       Date:  2009-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.